B2B Matchmaker for the pharmaceutical industry launched

Pharmatching_Logo

Freiburg, Germany, November 12, 2009 / b3c newswire / - Pharmatching.com, the first outsourcing portal of its kind for the life sciences and pharmaceutical industry, has been launched. The global B2B portal matches the demand against the supply of all services to be outsourced in the pharmaceutical industry and of active pharmaceutical ingredients. It is particularly advantageous for urgent projects where a service is immediately required or to offer capacities which are currently available.


On Pharmatching.com users post self-contained service requests and offers and receive responses directly from those who are interested and a good match. Thereafter the parties directly exchange further details by phone or email.


Pharmatching.com is useful for services in all categories and stages of drug development including contract manufacturing, contract research, laboratory investigations, contractual testing, non-clinical and clinical research, active pharmaceutical ingredients and consulting. The platform thus serves the whole value chain of medicinal products.


Dr. Gabriele Dallmann, founder and CEO of Pharmatching.com comments: “With the growing trend towards outsourcing and virtualization, the identification of suitable service and business partners has become a critical challenge. Pharmatching.com helps to accelerate drug development as it provides companies with an efficient tool to circumvent the time-consuming and expensive searching process”. 


Service buyers placing queries for services use the portal for free. Responses to such service requests, the placement of offered services and active pharmaceutical ingredients are subject to a service fee. During the launch phase of Pharmatching.com registration is free and special rates for the service fees are offered.


Pharmatching.com GmbH is located in Freiburg, Germany.

 

 

Contact
Dr. Gabriele Dallmann
Pharmatching GmbH
Wippertstr. 2
79100 Freiburg
Germany
Phone +49 (0)761 13734420
This email address is being protected from spambots. You need JavaScript enabled to view it.